Clinical Trial Update: Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating nivolumab in combination with decitabine and venetoclax for newly diagnosed TP53-mutated acute myeloid leukemia; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• OPDIVO (nivolumab)
• Venclexta (venetoclax)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2024-10-22